Octreotide for Pituitary Adenoma User Reviews
Brand names: Sandostatin, Sandostatin LAR Depot, Mycapssa, Bynfezia Pen
- akbraun
- Taken for 1 to 2 years
- March 6, 2014
"I was on this once a month before surgery, I found that overall I felt better. Didn't have the withdrawal that you can get on some medicines when it's close to time for the next dosage, but felt better after. The needle is very scary, but you really don't notice it being different from other shots. Very expensive."
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
More about octreotide
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (17)
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: somatostatin and somatostatin analogs
- Breastfeeding
- En español
Patient resources
- Octreotide oral/injection drug information
- Octreotide (Injection, Intramuscular, Subcutaneous) (Advanced Reading)
- Octreotide (Oral) (Advanced Reading)
- Octreotide Injection (Vials)
- Octreotide Long-Acting Injection
Other brands
Sandostatin, Sandostatin LAR Depot, Mycapssa, Bynfezia Pen
Professional resources
Other brands
Sandostatin, Mycapssa, Bynfezia Pen
"My pituitary adenoma was growing despite use of cabergoline. My endocrinologist suggested octreotide LAR. My tumor has decreased in size, prolactin levels have also decreased. I did experience gall bladder and GI issues. But the benefits are worth the side effects."